- $35.98m
- -$53.64m
- $19.89m
Brief: Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
Brief: Generation Bio Says Matthew Norkunas To Depart As CFO
Brief: Generation Bio Q3 EPS USD -0.23
Generation Bio Co expected to post a loss of 28 cents a share - Earnings Preview
Dyne Therapeutics slumps on safety concerns over drug trial, management changes
Generation Bio Co reports results for the quarter ended in June - Earnings Summary
Brief: Generation Bio Q2 EPS USD -0.31 Vs. IBES Estimate USD -0.28
Generation Bio Co expected to post a loss of 28 cents a share - Earnings Preview
Generation Bio Co reports results for the quarter ended in March - Earnings Summary
Brief: Generation Bio Q1 EPS USD -1.12
Generation Bio Co expected to post a loss of 41 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Biomea Fusion, BlackRock, Capital Bancorp
Generation Bio Co reports results for the quarter ended in December - Earnings Summary
Brief: Generation Bio Reports Business Highlights And Fourth Quarter And Full Year 2023 Financial Results
U.S. RESEARCH ROUNDUP-Eli Lilly, Five Below, Synopsys
Generation Bio Co expected to post a loss of 50 cents a share - Earnings Preview
Brief: Generation Bio Announces Breakthrough In Its Non-Viral Genetic Medicine Platform With Novel “Immune-Quiet” Dna
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Generation Bio Co reports results for the quarter ended in June - Earnings Summary